In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Making The Grade? Big Pharma Deals With Academia Begin To Score

Executive Summary

With three to four years in the books, Big Pharma’s updated tie-ups with academia have started to progress – some have even reached first-in-human stages, but these updated models have yet to produce any radical results that show they are an improvement over old-style partnerships.


Related Content

The Value Of Integrated R&D Sites
GSK’s Venture Deal With Avalon Yields Three Start-Ups In Two Years
J&J’s Approach To Sourcing Innovation: Closing The Networking Gap
BIO 2014 Tuesday Round-Up: AstraZeneca Looking Forward, Not Back
Pfizer’s CTI Shows Tangible Signs Of Progress In Its Junior Year
Bayer Establishes Workspace For Start-Ups In An Innovative Move
Back To School: Big Pharmas Test New Models For Tapping Academia


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts